Moran Kyle — SEC Form 4 filings
SEC reporting owner CIK 1657765. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-11.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-07 to 2026-02-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 4 filings — 296,400 shares, $4,402,973 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 50,000 shares @ $20.02 ($1,001,250) in Wave Life Sciences Ltd., filed 2025-12-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Wave Life Sciences Ltd. (WVE) | Chief Financial Officer | 7 | — | 9 legs · 296,400 sh · $4,402,973 | 17 |
Form 4 filings — Moran Kyle
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-11 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 45,625 @ $0 · Sale (S): 3,588 @ $13.45 · Grant/award (A): 273,750 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Wave Life Sciences Ltd. (WVE) | Option exercise (M): 60,000 @ $2.83 · Sale (S): 60,000 @ $13.20 · Option exercise (M): 100,000 @ $3.14 · Sale (S): 50,000 @ $15 · Sale (S): 50,000 @ $13.20 · Option exercise (M): 50,000 @ $4.75 · +10 more | EDGAR |
| 2025-02-06 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 42,000 @ $0 · Grant/award (A): 252,000 (derivative) @ $0 | EDGAR |
| 2024-10-11 | 4 | Wave Life Sciences Ltd. (WVE) | Option exercise (M): 25,000 @ $2.48 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Wave Life Sciences Ltd. (WVE) | Sale (S): 17,146 @ $9 | EDGAR |
| 2024-04-05 | 4 | Wave Life Sciences Ltd. (WVE) | Sale (S): 15,630 @ $6.17 | EDGAR |
| 2024-02-07 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 371,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1657765 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →